Susquehanna International Group, LLP Allogene Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 82,456 shares of ALLO stock, worth $187,175. This represents 0.0% of its overall portfolio holdings.

Number of Shares

82,456

Previous 87,742 6.02%

Holding current value

$187,175

Previous $204,000 12.75%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.08 - $3.5 $10,994 - $18,501	-5,286 Reduced 6.02%	82,456 $230,000
Q2 2024 Aug 15, 2024	SELL	$2.23 - $4.38 $17,982 - $35,320	-8,064 Reduced 8.42%	87,742 $204,000
Q1 2024 May 07, 2024	SELL	$2.92 - $5.63 $448,234 - $864,233	-153,505 Reduced 61.57%	95,806 $428,000
Q4 2023 Feb 14, 2024	SELL	$2.28 - $3.5 $175,685 - $269,692	-77,055 Reduced 23.61%	249,311 $800,000
Q3 2023 Nov 14, 2023	SELL	$3.17 - $5.96 $36,803 - $69,195	-11,610 Reduced 3.44%	326,366 $1.03 Million
Q2 2023 Aug 11, 2023	SELL	$4.53 - $6.74 $733,669 - $1.09 Million	-161,958 Reduced 32.4%	337,976 $1.68 Million
Q1 2023 May 16, 2023	BUY	$4.92 - $8.21 $2.14 Million - $3.57 Million	434,954 Added 669.37%	499,934 $2.47 Million
Q4 2022 Feb 14, 2023	SELL	$5.62 - $11.11 $776,903 - $1.54 Million	-138,239 Reduced 68.02%	64,980 $408,000
Q3 2022 Nov 14, 2022	BUY	$10.32 - $17.28 $426,288 - $713,784	41,307 Added 25.51%	203,219 $2.2 Million
Q2 2022 Aug 15, 2022	SELL	$6.78 - $12.28 $115,992 - $210,086	-17,108 Reduced 9.56%	161,912 $1.85 Million
Q1 2022 May 16, 2022	SELL	$7.65 - $15.29 $499,613 - $998,574	-65,309 Reduced 26.73%	179,020 $1.63 Million
Q4 2021 Feb 14, 2022	BUY	$13.13 - $24.52 $1.87 Million - $3.5 Million	142,706 Added 140.43%	244,329 $3.65 Million
Q3 2021 Nov 15, 2021	BUY	$21.01 - $27.64 $336,096 - $442,157	15,997 Added 18.68%	101,623 $2.61 Million
Q2 2021 Aug 11, 2021	SELL	$23.49 - $35.8 $1.61 Million - $2.46 Million	-68,624 Reduced 44.49%	85,626 $2.23 Million
Q1 2021 May 17, 2021	BUY	$25.79 - $39.02 $2.38 Million - $3.61 Million	92,410 Added 149.43%	154,250 $5.45 Million
Q4 2020 Feb 16, 2021	BUY	$25.24 - $43.45 $1.02 Million - $1.75 Million	40,388 Added 188.27%	61,840 $1.56 Million
Q3 2020 Nov 16, 2020	SELL	$32.38 - $44.96 $89,401 - $124,134	-2,761 Reduced 11.4%	21,452 $809,000
Q2 2020 Aug 14, 2020	SELL	$18.39 - $54.04 $436,026 - $1.28 Million	-23,710 Reduced 49.48%	24,213 $1.04 Million
Q1 2020 May 15, 2020	BUY	$18.22 - $28.25 $318,412 - $493,697	17,476 Added 57.4%	47,923 $932,000
Q3 2019 Nov 14, 2019	SELL	$26.11 - $32.99 $293,319 - $370,609	-11,234 Reduced 26.95%	30,447 $830,000
Q2 2019 Aug 16, 2019	BUY	$25.56 - $31.09 $1.07 Million - $1.3 Million	41,681 New	41,681 $1.12 Million

Others Institutions Holding ALLO

# of Institutions

162

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Allogene Therapeutics, Inc. Transaction History